Middletown Life

Author: Two Bear Capital

Inimmune Completes Enrollment and Doses First Patient in Phase 2 Chamber Trial of INI-2004 for Allergic Rhinitis

March 12, 2026
Inimmune Strengthens Leadership Team Ahead of Phase 2 INI-2004 Allergic Rhinitis Data Readout

March 5, 2026
PULSEDATA AI ANNOUNCES STRATEGIC PARTNERSHIP WITH CALCIUM HEALTH TO STRENGTHEN CHRONIC CONDITION MANAGEMENT IN VALUE-BASED CARE

February 24, 2026
Selector Raises $32 Million to Eliminate Downtime with AI-Powered Observability

February 18, 2026
FYR Bio Appoints Barbara K. Zehentner, MBA, PhD, HCLD (ABB), as Chief Operating Officer

February 12, 2026
Selector Achieves Major Innovation Milestone with Eight U.S. Patents Granted in AI-Powered Network Intelligence

January 20, 2026
Inimmune Commences Pivotal Phase 2 Allergy Trial of INI-2004 in Allergic Rhinitis Patients

January 7, 2026
Novoron Bioscience Awarded $2.5 Million NIH/NIA SBIR Grant to Accelerate Alzheimer’s Drug Discovery with Human Brain Organoids

January 6, 2026
TileDB Announces Integration with Snowflake to Launch TileDB Carrara to Bridge Scientific and Multimodal Data in AI Data Cloud

December 20, 2025
TileDB Announces Integration with Snowflake to Launch TileDB Carrara to Bridge Scientific and Multimodal Data in AI Data Cloud

December 19, 2025